Overview
Shanlin Chen practices in Beijing, China. Chen is rated as an Advanced expert by MediFind in the treatment of Macrodactyly of the Foot. Their top areas of expertise are Congenital Radioulnar Synostosis, Wildervanck Syndrome, Holt-Oram Syndrome, Osteotomy, and Bone Graft.
Their clinical research consists of co-authoring 46 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 2 articles in the study of Macrodactyly of the Foot.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Congenital Radioulnar Synostosis
- Holt-Oram SyndromeChen isDistinguished. Learn about Holt-Oram Syndrome.
- Wildervanck SyndromeChen isDistinguished. Learn about Wildervanck Syndrome.
- Advanced
- Brachydactyly Type CChen isAdvanced. Learn about Brachydactyly Type C.
- Camptodactyly Fibrous Tissue Hyperplasia Skeletal Dysplasia
- Camptodactyly Syndrome Guadalajara Type 1
- Camptodactyly Syndrome Guadalajara Type 2
- Camptodactyly Taurinuria
- Macrodactyly of the Foot
- Experienced
- Atrial Septal Defect (ASD)Chen isExperienced. Learn about Atrial Septal Defect (ASD).
- Bone GraftChen isExperienced. Learn about Bone Graft.
- BrachydactylyChen isExperienced. Learn about Brachydactyly.
- OsteotomyChen isExperienced. Learn about Osteotomy.
- Primary AmyloidosisChen isExperienced. Learn about Primary Amyloidosis.